Advertisement

Topics

Rasna Therapeutics, Inc. Company Profile

21:23 EDT 29th May 2017 | BioPortfolio

Rasna Therapeutics, Inc. is a development stage biotechnology company focused primarily on the high unmet need that exists for leukemias. Rasna’s primary indication is acute myeloid leukemia (AML) which may be fatal within weeks to months, has a 5-year survival rate of only about 25% and very poor prospects for long-term survival of patients. The company’s clinical program is focused on three druggable intervention points with potential to improve safety and efficacy of current AML combination therapies, around which is has robust IP and substantial freedom to operate: RASP-101, an established anticancer therapeutic for treating nucleophosmin (NPM1) mutated acute myeloid leukemia (AML); RASP-201, an inhibitor of lysine specific histone demethylase 1 (LSD1 or KDM1A), which is overexpressed in several human cancers including AML plays an important role in epigenetic modification that contributes to cellular proliferation; and, RASP-301, high affinity, NPM1 binding molecules exhibiting selective cytotoxic activity on AML cells.


News Articles [1988 Associated News Articles listed on BioPortfolio]

Rasna Therapeutics, Inc. Closes Private Placement of $2 Million

Tuesday, December 27th 2016 at 12:16pm UTC NEW YORK–(BUSINESS WIRE)– Rasna Therapeutics, Inc. (OTCQB:RASP), a development stage biotechnology company focused on the development of cancer d...

Now Introducing Rasna Therapeutics

Rasna Therapeutics completes private placement

Rasna Therapeutics Names Dr. As New CEO

  Life Sciences Jobs   ...

Rasna Therapeutics Announces Upgrade To OTCQX

  Life Sciences Jobs   ...

Rasna Therapeutics Closes Private Placement Of $2 Million

  Life Sciences Jobs   ...

Rasna Therapeutics Advances Development Of A Novel Treatment For NPM1-Mutated Acute Myeloid Leukemia

  Life Sciences Jobs   ...

Rasna Therapeutics Announces Upgrade to OTCQX®

Rasna Therapeutics, Inc. (OTCQX:RASP), a clinical-stage biotechnology company focused on delivering novel therapeutics and biomarkers for acute myeloid leukemia (AML) patients, to...

Clinical Trials [108 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1116 Associated Companies listed on BioPortfolio]

Rasna Therapeutics , Inc.

Rasna Therapeutics, Inc. is a biotechnology company focused primarily on the high unmet need that exists for leukemias. Rasna’s primary indication is acute myeloid leukemia (...

Rasna Therapeutics, Inc.

Rasna Therapeutics, Inc. is a development stage biotechnology company focused primarily on the high unmet need that exists for leukemias. Rasna’s primary indication is acute ...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Rasna Therapeutics, Inc." on BioPortfolio

We have published hundreds of Rasna Therapeutics, Inc. news stories on BioPortfolio along with dozens of Rasna Therapeutics, Inc. Clinical Trials and PubMed Articles about Rasna Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rasna Therapeutics, Inc. Companies in our database. You can also find out about relevant Rasna Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record